Immune-related adverse events in urothelial cancer patients: Adjustment for immortal time bias.
Cancer Sci
; 113(11): 3912-3921, 2022 Nov.
Article
in En
| MEDLINE
| ID: mdl-35997546
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Urinary Bladder Neoplasms
/
Carcinoma, Transitional Cell
/
Antineoplastic Agents, Immunological
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Cancer Sci
Year:
2022
Type:
Article
Affiliation country:
Japan